Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
398 Results Found
AHA 340B Advocacy Alliance
A Bloomberg article published today (linked here and text below) discusses how the Department of Health and Human Services plans to “survey safety-net hospitals on the amount they pay for prescription drugs, following up on an effort to reduce the hospitals’ Medicare drug reimbursement during the president’s first term.”
Rural Health Services
Over 57 million rural Americans depend on their hospital as an important source of care as well as a critical component of their area's economic and social fabric. Location, size, workforce, payment and access to capital challenge small or rural hospitals and the communities they serve. Collaborating with state and regional hospital associations and with advice from its member council, the Section tracks the issues, develops policies and identifies solutions to our most pressing problems.
Aetna Delays, Issues Additional Details on ‘Level of Severity Inpatient Payment’ Policy
The Centers for Medicare & Medicaid Services (CMS) Oct. 31 issued a final rule that updates physician fee schedule (PFS) payments for calendar year (CY) 2026.
Senate Deal Reached to End Government Shutdown
Over the weekend, senators reached a deal to reopen the government. The agreement includes a three-bill, full-year spending package for 1) the Department of Agriculture and Food and Drug Administration, 2) the Legislative Branch, and 3) the Defense Department construction projects and the Department of Veterans Affairs, as well as a short-term continuing resolution to extend funding for the rest of the government until Jan. 30, 2026.
Fact Sheet: 340B Drug Pricing Program: Fact vs Fiction
For nearly 30 years, the 340B Drug Pricing Program has provided financial help to safety-net hospitals to manage rising prescription drug costs. Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to qualifying health care organizations that care for many uninsured and low-income patients.
CMS Issues CY 2026 Physician Fee Schedule Final Rule
The Centers for Medicare & Medicaid Services (CMS) Oct. 31 issued a final rule that updates physician fee schedule (PFS) payments for calendar year (CY) 2026.
Letter from AHA, Other Organizations in Support of RESULTS Act (S. 2761/H.R. 5269)
AHA and other health organizations urge Congress to protect patient access to clinical laboratory services by enacting needed reforms to the Medicare Clinical Laboratory Fee Schedule (CLFS).
AHA 340B Advocacy Alliance Bulletin - October 30, 2025
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan. 1, 2026.
340B Advocacy Alliance Bulletin - October 23, 2025
The Senate Committee on Health, Education, Labor and Pensions today held a hearing discussing the 340B Drug Pricing Program and its growth and impacts on patients.
AHA Statement Before the Senate HELP Committee on “The 340B Program: Examining Its Growth and Impact on Patients”
AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and communities they serve.